SBL#1

N/A

Report date: 2025/04/22 14:43:18
NME

Base Information

Drug NameSBL#1
Drug Alias NameSBL#1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcute liver injuryLiver Failure, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeaBeLife Biotech
China Registration ClassN/A

Develop Information

Active CompaniesSeaBeLife Biotech
Inactive CompaniesN/A
Active IndicationsAcute liver injuryLiver Failure, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A